Thus, these prognostic factors, i.e., clinicopathological features of the primary melanoma, anatomic site of distant metastases, and baseline serum S100B and LDH levels are good candidates for a multivariable prognostic model, but validation is needed. This evidence concerns the gene S100B and melanoma.